PROTALIX BIOTHERAPEUTICS

Protalix is a biopharmaceutical company that is revolutionizing the development and manufacturing of recombinant therapeutic proteins through its ProCellEx® plant cell-based protein expression system. Using ProCellEx, Protalix is focused on the development and commercialization of a proprietary pipeline of novel and biosimilar proteins that target large, established pharmaceutical markets and that rely upon known biological mechanisms of action. Protalix’s initial commercial focus is on compl... ex therapeutic proteins for the treatment of genetic disorders, such as Gaucher disease and Fabry disease. Protalix is also advancing additional recombinant biopharmaceutical drug development programs, including a TNF inhibitor for inflammatory diseases. Protalix’s pipeline is led by ELELYSO™(taliglucerase alfa for injection), which received approval from the U.S. Food and Drug Administration on May 1, 2012. ELELYSO is the first FDA-approved plant cell-based recombinant therapeutic protein. Protalix has partnered with Pfizer for worldwide development and commercialization of ELELYSO, excluding Israel, where Protalix has retained full rights. Marketing applications for taliglucerase alfa have been submitted for Europe, Israel, Brazil and Australia, with additional regulatory submissions in progress.

#SimilarOrganizations #People #Financial #Website #More

PROTALIX BIOTHERAPEUTICS

Industry:

Biotechnology Manufacturing Pharmaceutical Therapeutics

Founded:

1994-01-01

Address:

Carmiel, HaZafon, Israel

Country:

Israel

Website Url:

http://www.protalix.com

Total Employee:

501+

Status:

Active

Contact:

972-4-902-8100

Email Addresses:

[email protected]

Total Funding:

159.9 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress

Similar Organizations

axcella-logo

Axcella

Axcella is a biotechnology company providing therapeutics development solutions.

crinetics-pharmaceuticals-logo

Crinetics Pharmaceuticals

Crinetics is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics.

imvax-logo

Imvax

Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.

Current Advisors List

not_available_image

Zeev Bronfeld Chairman @ Protalix BioTherapeutics
Board_member

Current Employees Featured

not_available_image

Yoseph Shaaltiel
Yoseph Shaaltiel Founder & Executive Vice President, Research and Development @ Protalix BioTherapeutics
Founder & Executive Vice President, Research and Development

not_available_image

Yaron Naos
Yaron Naos SVP, Operations @ Protalix BioTherapeutics
SVP, Operations

not_available_image

Yoseph Shaaltiel
Yoseph Shaaltiel EVP, Research and Development @ Protalix BioTherapeutics
EVP, Research and Development

dror-bashan_image

Dror Bashan
Dror Bashan President & CEO @ Protalix BioTherapeutics
President & CEO
2019-01-01

Founder

not_available_image

Yoseph Shaaltiel

Stock Details

Company's stock symbol is TLV:PLX

Investors List

cybele-holdings_image

Official Site Inspections

http://www.protalix.com Semrush global rank: 4.65 M Semrush visits lastest month: 2.11 K

Host Informations
Whois Informations

Loading ...